Pharmacotherapy before and after endovascular intervention in peripheral artery disease

From recommendations to drug administration

Thursday, March 18, 2021

Tomislav Krčmar, M.D., Ph.D.
University Hospital Centre Zagreb
Clinical Hospital Centre Rijeka

Prof. Kristina Selthofer-Relatić, M.D., Ph.D.
University Hospital Centre Osijek

Prof. Mislav Vrsalović, M.D., Ph.D.
University Hospital Centre Sestre Milosrdnice

Webinar

Required level of previous knowledge and experience of participants: basic to intermediate

Webinar objectives:

  • Explain why it is important to identify patients with peripheral artery disease (PAD) in time and treat them adequately with drugs
  • Introduce participants to cardiovascular risk in patients with PAD
  • Define groups of drugs that should be prescribed to a patient with PAD for regular use
  • Clarify the role of antiplatelet therapy in patients with PAD (in optimal medical therapy, after endovascular intervention and after surgical revascularization)
  • Explain new possibilities in antiplatelet treatment of PAD and the impact of new antiplatelet drugs on disease course, cardiovascular and overall mortality
  • Inform the participants about the recommendations of the European professional societies on adequate antiplatelet therapy of patients with PAD
  • Provide the participants with all the information necessary for independent selection of antiplatelet drugs and their combinations in patients with PAD

Who is the webinar for:

  • All physicians involved in the active treatment of patients with peripheral arterial disease: cardiologists, vascular surgeons, interventional radiologists, diabetologists, family physicians and residents in all these specialities.
17:00-17:05Peripheral artery disease and cardiovascular risk
Tomislav Krčmar, M.D., Ph.D
17:05-17:25Drugs that every patient with PAD should have prescribed in therapy
Prof. Kristina Selthofer-Relatić, M.D., Ph.D.
Discussion – questions and answers
17:25-17:45Antiplatelet therapy of patients before and after endovascular interventions in PAD (review of guidelines and COMPASS study)
Prof. Mislav Vrsalović, M.D., Ph.D.
Discussion - questions and answers
17:45-18:05Novelties in antiplatelet therapy after the VOYAGER-PAD study
Tomislav Krčmar, M.D., Ph.D.
Discussion - questions and answers
18:05-18:15Discussion and conclusions

Croatian is the official language of the Webinar, for registration please visit here